A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma.
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Lapatinib (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2014 Actual end date changed from to 1 Jan 2011 to 1 Nov 2007 as reported by ClinicalTrials.gov record.
- 26 Apr 2012 Actual patients number is 24 as reported by ClinicalTrials.gov.
- 18 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.